[VRTX] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
25-Oct-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -37.91%
YoY- 225.05%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 941,293 858,435 870,106 784,535 752,157 640,799 651,634 27.87%
PBT 327,138 320,165 32,497 136,511 216,591 214,642 112,442 104.19%
Tax 59,711 51,534 -1,492,599 8,055 10,341 -12,659 10,257 224.65%
NP 267,427 268,631 1,550,527 128,746 207,360 210,263 100,684 92.13%
Tax Rate -18.25% -16.10% 4,593.04% -5.90% -4.77% 5.90% -9.12% -
Total Cost 673,866 589,804 -680,421 655,789 544,797 430,536 550,950 14.41%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 28.41 31.29 178.20 16.41 27.57 32.81 15.45 50.26%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS 1.04 1.05 6.08 0.51 0.82 0.83 0.40 89.41%
EPS Diluted 1.03 1.03 5.97 0.50 0.80 0.81 0.39 91.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.